Henry Schein (HSIC) Updates 2026 Sales Outlook
Henry Schein (NASDAQ: HSIC) revised its 2026 sales growth forecast higher, prompting investors to re-evaluate their positions. The medical supply distributor's updated outlook signals potential shifts in its forward-looking revenue trajectory amid evolving market conditions.
If Henry Schein's raised sales guidance for 2026 proves durable, investors may look to $HSIC+WL for potential upside.